JAC Advance Access originally published online on September 8, 2008
Journal of Antimicrobial Chemotherapy 2008 62(6):1463-1464; doi:10.1093/jac/dkn389
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Research letters |
Susceptibility testing of tigecycline against Acinetobacter spp. by disc diffusion method: withdrawing a therapeutic option by varying the Mueller–Hinton agar?
1 Laboratorio de Microbiología, Hospital Alemán, Buenos Aires, Argentina 2 Laboratorio Domingo I Nanni, Paraná, Argentina
* Correspondence address. Colón 128, 3100 Paraná, Entre Rios, Argentina. Tel: +54-343-4310783; Fax: +54-343-4232340; E-mail: cbantar@arnet.com.ar
Keywords: tetracyclines , susceptibility tests , antimicrobial resistance
| The first 10% of the full text of this article appears below. |
Sir,
We read with interest the letter published by Thamlikitkul and Tiengrim.1 They found that the susceptibility of several Acinetobacter spp. isolates varied according to the commercial Mueller–Hinton agar (MHA) used in the disc diffusion test, probably as a consequence of the higher content of manganese in the Oxoid MHA, when compared with that from Becton-Dickinson. In fact, they have previously noted the lack of correlation between the disc
| Funding |
|---|
| Transparency declarations |
|---|